Related Experiment Videos
Selectively predictive calcium supplementation using NCCN risk stratification system after thyroidectomy with
Ronghao Sun1, Jie Zhang2, Fenghua Zhang2
1Department of Head and Neck Surgery, Sichuan Cancer Hospital Chengdu 610041, China.
International Journal of Clinical and Experimental Medicine
|February 18, 2016
Summary
Post-thyroidectomy hypocalcemia can be predicted using the NCCN risk stratification system. Selective calcium supplementation is recommended for high-risk differentiated thyroid carcinoma patients.
Area of Science:
- Endocrinology
- Oncology
- Surgical Research
Background:
- Post-thyroidectomy hypocalcemia is a frequent complication.
- Predicting hypocalcemia and optimizing calcium supplementation are crucial for surgeons.
Purpose of the Study:
- To evaluate the NCCN risk stratification system for predicting hypocalcemia after differentiated thyroid carcinoma surgery.
- To determine optimal calcium supplementation strategies based on risk stratification.
Main Methods:
- 132 differentiated thyroid carcinoma patients were stratified into four risk groups (A-D) based on surgery type and neck dissection.
- Groups received varying calcium supplementation (oral, intravenous, or none).
- Serum calcium and parathyroid hormone levels were monitored, and hypocalcemia incidence was recorded.
Main Results:
- Group A (low-risk) showed no significant calcium/PTH changes. Group B (high-risk, no supplement) had significant decreases and the highest hypocalcemia incidence.
- Intravenous calcium in Group D led to faster serum calcium recovery.
- Hypocalcemia incidence was significantly lower in Group A and Group D compared to other groups.
Conclusions:
- The NCCN risk stratification system effectively predicts post-thyroidectomy hypocalcemia in differentiated thyroid carcinoma patients.
- Selective calcium supplementation, particularly intravenous for high-risk patients, is recommended.